SCHEMBL6280282

SCHEMBL6280282

COc1cccc(SCC(=O)c2ccc(O)cc2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 4/20 0.51
MTNR1B P49286 4/20 0.51
ESR2 Q92731 1/20 0.49
ALDH1A1 P00352 2/20 0.48
MAPT P10636 2/20 0.48
HSD11B1 P28845 1/20 0.48
NPC1 O15118 3/20 0.47
RAB9A P51151 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
POLB P06746 1/20 0.46
HDAC3 O15379 3/20 0.46
HDAC4 P56524 3/20 0.46
HDAC1 Q13547 3/20 0.46
HDAC7 Q8WUI4 3/20 0.46
HDAC2 Q92769 3/20 0.46
HDAC10 Q969S8 3/20 0.46
HDAC11 Q96DB2 3/20 0.46
HDAC8 Q9BY41 3/20 0.46
HDAC6 Q9UBN7 3/20 0.46
HDAC9 Q9UKV0 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2499199 0.92 NPC1 (0.56) MTNR1AMTNR1BALDH1A1MAPTHSD11B1
SCHEMBL11599893 0.89 ALDH1A1 (0.59) MTNR1AMTNR1BALDH1A1MAPTHSD11B1
SCHEMBL30610971 0.88 ALDH1A1 (0.56) MTNR1AMTNR1BALDH1A1MAPTHSD11B1
SCHEMBL5043303 0.88 NPC1 (0.52) MTNR1AMTNR1BALDH1A1MAPTHSD11B1
SCHEMBL5045385 0.88 ALDH1A1 (0.56) MTNR1AMTNR1BALDH1A1MAPTHSD11B1
SCHEMBL29766169 0.88 NPC1 (0.52) MTNR1AMTNR1BALDH1A1MAPTHSD11B1
SCHEMBL6281255 0.86 NPC1 (0.53) ALDH1A1MAPTHSD11B1NPC1RAB9A
SCHEMBL8597033 0.85 ALDH1A1 (0.52) MTNR1AMTNR1BALDH1A1MAPTNPC1
SCHEMBL7455676 0.83 NPC1 (0.50) MTNR1AMTNR1BALDH1A1HSD11B1NPC1
SCHEMBL6280624 0.82 KMT2A (0.49) ALDH1A1MAPTNPC1RAB9APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6921827-B2 Process for preparing 3-aryl-benzo{b} thiophenes ELI LILLY AND COMPANY (US) 2005-07-26 US disclosed
US-20040132775-A1 Process for preparing 3-aryl-benzo{b} thiophenes LUKE WAYNE DOUGLAS (US) 2004-07-08 US disclosed
WO-2002042261-A2 PROCESS FOR PREPARING α-(3-ARYLTHIO)-ACETOPHENONES ELI LILLY AND COMPANY (US) 2002-05-30 WO disclosed
US-4075227-A NONSTEROIDAL ELI LILLY AND COMPANY (US) 1978-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040132775-A1 Process for preparing 3-aryl-benzo{b} thiophenes TBCB, CYP1B1, TST MTNR1A 4516/4885MTNR1B 3199/4885ESR2 3551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.